Testing Frequency Matters: An Evaluation of the Diagnostic Performance of a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Rapid Antigen Test in US Correctional Facilities. (6th July 2022)

• Record Type: Journal Article
• Authors: Lind, Margaret L; Schultes, Olivia L; Robertson, Alexander J; Houde, Amy J; Cummings, Derek A T; Ko, Albert I; Kennedy, Byron S; Richeson, Robert P
• Is Part Of: Clinical infectious diseases. Volume 76:Number 3(2023)
• Page Start: e327
• Page End: e335
• Publication Date: 2022-07-06
• Subjects: diagnostic accuracy -- COVID-19 -- rapid antigen test -- correctional facility; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciac450
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Background: The Centers for Disease Control and Prevention recommends serial rapid antigen assay collection within congregate facilities. Although modeling and observational studies from communities and long-term care facilities have shown serial collection provides adequate sensitivity and specificity, the accuracy within correctional facilities remains unknown. Methods: Using Connecticut Department of Correction data from 21 November 2020 to 15 June 2021, we estimated the accuracy of a rapid assay, BinaxNOW (Abbott), under 3 collection strategies: single test collection and serial collection of 2 and 3 tests separated by 1–4 days. The sensitivity and specificity of the first (including single), second, and third serially collected BinaxNOW tests were estimated relative to RT-PCRs collected ≤1 day of the BinaxNOW test. The accuracy metrics of the testing strategies were then estimated as the sum (sensitivity) and product (specificity) of tests in each strategy. Results: Of the 13 112 residents who contributed ≥1 BinaxNOW test during the study period, 3825 contributed ≥1 RT-PCR paired BinaxNOW test. In relation to RT-PCR, the 3-rapid-antigen-test strategy had a sensitivity of 95.9% (95% CI: 93.6–97.5%) and specificity of 98.3% (95% CI: 96.7–99.1%). The sensitivities of the 2- and 1-rapid-antigen-test strategies were 88.8% and 66.8%, and the specificities were 98.5% and 99.4%, respectively. The sensitivity was higher among symptomatic residents and when RT-PCRs were collected before BinaxNOW tests. Conclusions: We found serial antigen test collection resulted in high diagnostic accuracy. These findings support serial collection for outbreak investigation, screening, and when rapid detection is required (such as intakes or transfers). Abstract : Through the evaluation of the BinaxNOW rapid antigen test under varying collection frequency strategies, we provide evidence of the utility of serial rapid antigen test collection within congregate facility settings for outbreak investigation, screening, and when rapid detection is required.